Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000113

SVP & Chief Accounting Officer sold 240 shares at $419.00 ($100,560)

  • SVP & Chief Accounting Officer gave up 225 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ambrose Kristen · SVP & Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-01 Shares withheld for taxes : show line 1 in the form 10b5-1 −225 $418.10 $94,073 7,740 D
2024-04-02 Sale : show line 2 in the form 10b5-1 −240 $419.00 $100,560 7,500 D
Open-market sales · 240 sh · avg $419.00 · $100,560
Loading xslF345X05/wk-form4_1712174533.xml…